CTRI/2022/11/047491Completed未知
An Observational, Retrospective, Multicentric study to Evaluate the Functional Outcomes in Patients Who Underwent Arthroscopic Shoulder Ligament Tear Repair Using Sironix Suture Anchor
Trial Snapshot
- Phase
- 未知
- Status
- Completed
- Sponsor
- Healthium Medtech Limited
- Enrollment
- 75
Study Overview
Brief Summary
No summary available.
Study Design
- Study Type
- Observational
Eligibility Criteria
Inclusion Criteria
- •1. Male/ Female Patients of 18 to 80 years of age.
- •2. Patients who underwent arthroscopic shoulder ligament tears repair using Sironix suture anchor between the period of Apr 2018 to July 2022.
- •3. Patient willing to give written informed consent to participate in the study when attending an in-clinic follow-up visit, or providing verbal consent during the telephonic follow-up visit.
Exclusion Criteria
- •1. Patients not responding to calls after three attempts or not interested to participate in the study.
- •2. Patients with traumatic injury to the same shoulder post shoulder ligament tears repair procedure.
Investigators
Similar Trials
Completed
Not Applicable
To understand demographics, diagnosis, clinical presentation and management of patients with Acid peptic disorders (APD) in IndiaCTRI/2022/09/045446Dr Reddys Laboratories Ltd
Not yet recruiting
Unknown
Assessment of Stent in Symptomatic Ischemic Heart Disease: A Retrospective AnalysisCTRI/2024/06/069583SMC Heart Institute and IVF Research Centre
Completed
Unknown
Study to evaluate prevalence of Non-Alcoholic Steatohepatitis diagnosed through transient elastography & evaluate performance of various non-invasive liver fibrosis scores in Indian type 2 diabetes mellitus patientsCTRI/2023/08/056193Dr Debmalya Sanyal351
Not yet recruiting
Not Applicable
ong term survival and complications in patients operated for Prosthetic heart valves on Nicoumalone(Acenocoumarol) and tissue valve outcomesCTRI/2022/01/039268Abbott Healthcare Pvt Ltd
Completed
Not Applicable
Observational study of pregnancy kit for rapid detection of pregnancy.CTRI/2022/03/041516Mankind Pharma Limited Mankind Pharma Limited